Mallinckrodt Pharmaceuticals RX
FDA Approved Drugs
Mallinckrodt Pharmaceuticals RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 119
- Latest Approval Date Jun 03, 2026
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Company
Mallinckrodt Pharmaceuticals RX
Country
Ireland
Website
Social Profiles
Company Snapshot
Mallinckrodt Pharmaceuticals RX
College Business & Technology Park Cruiserath, Blanchardstown Dublin 15
Ireland
www.mallinckrodt.com/ simon.plevin@mnk.com View on MapFDA Approved Drug Records ( 119 records )
Drug Name
ACETAMINOPHEN AND CODEINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
300MG;15MG
Approval Date
2001-05-31
Active Ingredient
ACETAMINOPHEN; CODEINE PHOSPHATE
Application Number
40419
Product Number
1
Dosage Form
-
Strength
300MG;15MG
Approval Date
2001-05-31
Regulatory Status
RX
Drug Name
ACETAMINOPHEN AND CODEINE PHOSPHATE
Product Number
2
Dosage Form
-
Strength
300MG;30MG
Approval Date
2001-05-31
Active Ingredient
ACETAMINOPHEN; CODEINE PHOSPHATE
Application Number
40419
Product Number
2
Dosage Form
-
Strength
300MG;30MG
Approval Date
2001-05-31
Regulatory Status
RX
Drug Name
ACETAMINOPHEN AND CODEINE PHOSPHATE
Product Number
3
Dosage Form
-
Strength
300MG;60MG
Approval Date
2001-05-31
Active Ingredient
ACETAMINOPHEN; CODEINE PHOSPHATE
Application Number
40419
Product Number
3
Dosage Form
-
Strength
300MG;60MG
Approval Date
2001-05-31
Regulatory Status
RX
Drug Name
AMPHETAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2021-01-22
Active Ingredient
AMPHETAMINE SULFATE
Application Number
213583
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2021-01-22
Regulatory Status
RX
Drug Name
AMPHETAMINE SULFATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2021-01-22
Active Ingredient
AMPHETAMINE SULFATE
Application Number
213583
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2021-01-22
Regulatory Status
RX
Drug Name
ANAFRANIL
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
1989-12-29
Active Ingredient
CLOMIPRAMINE HYDROCHLORIDE
Application Number
19906
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
1989-12-29
Regulatory Status
RX
Drug Name
ANAFRANIL
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
1989-12-29
Active Ingredient
CLOMIPRAMINE HYDROCHLORIDE
Application Number
19906
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
1989-12-29
Regulatory Status
RX
Drug Name
ANAFRANIL
Product Number
3
Dosage Form
-
Strength
75MG
Approval Date
1989-12-29
Active Ingredient
CLOMIPRAMINE HYDROCHLORIDE
Application Number
19906
Product Number
3
Dosage Form
-
Strength
75MG
Approval Date
1989-12-29
Regulatory Status
RX
Drug Name
ANEXSIA 5/325
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
2000-10-20
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
40409
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
2000-10-20
Regulatory Status
RX
Drug Name
ANEXSIA 7.5/325
Product Number
1
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2000-09-08
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
40405
Product Number
1
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2000-09-08
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2025-12-10
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE
Application Number
218473
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2025-12-10
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2025-12-10
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE
Application Number
218473
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2025-12-10
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE;EQ 0.5MG BASE
Approval Date
2017-12-13
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Application Number
207000
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE;EQ 0.5MG BASE
Approval Date
2017-12-13
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE;EQ 2MG BASE
Approval Date
2017-12-13
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Application Number
207000
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE;EQ 2MG BASE
Approval Date
2017-12-13
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
1
Dosage Form
-
Strength
1.25MG;1.25MG;1.25MG;1.25MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
1
Dosage Form
-
Strength
1.25MG;1.25MG;1.25MG;1.25MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
2
Dosage Form
-
Strength
1.875MG;1.875MG;1.875MG;1.875MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
2
Dosage Form
-
Strength
1.875MG;1.875MG;1.875MG;1.875MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
3
Dosage Form
-
Strength
2.5MG;2.5MG;2.5MG;2.5MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
3
Dosage Form
-
Strength
2.5MG;2.5MG;2.5MG;2.5MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
4
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
4
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
5
Dosage Form
-
Strength
3.75MG;3.75MG;3.75MG;3.75MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
5
Dosage Form
-
Strength
3.75MG;3.75MG;3.75MG;3.75MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
6
Dosage Form
-
Strength
5MG;5MG;5MG;5MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
6
Dosage Form
-
Strength
5MG;5MG;5MG;5MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
7
Dosage Form
-
Strength
7.5MG;7.5MG;7.5MG;7.5MG
Approval Date
2003-10-07
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40440
Product Number
7
Dosage Form
-
Strength
7.5MG;7.5MG;7.5MG;7.5MG
Approval Date
2003-10-07
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
1
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2023-08-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211546
Product Number
1
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2023-08-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
2
Dosage Form
-
Strength
6.25MG;6.25MG;6.25MG;6.25MG
Approval Date
2023-08-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211546
Product Number
2
Dosage Form
-
Strength
6.25MG;6.25MG;6.25MG;6.25MG
Approval Date
2023-08-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
3
Dosage Form
-
Strength
9.375MG;9.375MG;9.375MG;9.375MG
Approval Date
2023-08-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211546
Product Number
3
Dosage Form
-
Strength
9.375MG;9.375MG;9.375MG;9.375MG
Approval Date
2023-08-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
4
Dosage Form
-
Strength
12.5MG;12.5MG;12.5MG;12.5MG
Approval Date
2023-08-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211546
Product Number
4
Dosage Form
-
Strength
12.5MG;12.5MG;12.5MG;12.5MG
Approval Date
2023-08-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
1
Dosage Form
-
Strength
1.25MG;1.25MG;1.25MG;1.25MG
Approval Date
2019-04-22
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211547
Product Number
1
Dosage Form
-
Strength
1.25MG;1.25MG;1.25MG;1.25MG
Approval Date
2019-04-22
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
2
Dosage Form
-
Strength
2.5MG;2.5MG;2.5MG;2.5MG
Approval Date
2019-04-22
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211547
Product Number
2
Dosage Form
-
Strength
2.5MG;2.5MG;2.5MG;2.5MG
Approval Date
2019-04-22
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
3
Dosage Form
-
Strength
3.75MG;3.75MG;3.75MG;3.75MG
Approval Date
2019-04-22
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211547
Product Number
3
Dosage Form
-
Strength
3.75MG;3.75MG;3.75MG;3.75MG
Approval Date
2019-04-22
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
4
Dosage Form
-
Strength
5MG;5MG;5MG;5MG
Approval Date
2019-04-22
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211547
Product Number
4
Dosage Form
-
Strength
5MG;5MG;5MG;5MG
Approval Date
2019-04-22
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
5
Dosage Form
-
Strength
6.25MG;6.25MG;6.25MG;6.25MG
Approval Date
2019-04-22
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211547
Product Number
5
Dosage Form
-
Strength
6.25MG;6.25MG;6.25MG;6.25MG
Approval Date
2019-04-22
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
6
Dosage Form
-
Strength
7.5MG;7.5MG;7.5MG;7.5MG
Approval Date
2019-04-22
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
211547
Product Number
6
Dosage Form
-
Strength
7.5MG;7.5MG;7.5MG;7.5MG
Approval Date
2019-04-22
Regulatory Status
RX
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2002-01-29
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
40436
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2002-01-29
Regulatory Status
RX
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2002-01-29
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
40436
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2002-01-29
Regulatory Status
RX
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2003-05-06
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
76353
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2003-05-06
Regulatory Status
RX
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2003-05-06
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
76353
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2003-05-06
Regulatory Status
RX
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2003-05-06
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
76353
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2003-05-06
Regulatory Status
RX
Drug Name
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
Product Number
1
Dosage Form
-
Strength
0.025MG;2.5MG
Approval Date
2020-10-06
Active Ingredient
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
Application Number
213335
Product Number
1
Dosage Form
-
Strength
0.025MG;2.5MG
Approval Date
2020-10-06
Regulatory Status
RX
Drug Name
FENTANYL-100
Product Number
4
Dosage Form
-
Strength
100MCG/HR
Approval Date
2011-02-09
Active Ingredient
FENTANYL
Application Number
77154
Product Number
4
Dosage Form
-
Strength
100MCG/HR
Approval Date
2011-02-09
Regulatory Status
RX
Drug Name
FENTANYL-12
Product Number
5
Dosage Form
-
Strength
12.5MCG/HR
Approval Date
2015-06-11
Active Ingredient
FENTANYL
Application Number
77154
Product Number
5
Dosage Form
-
Strength
12.5MCG/HR
Approval Date
2015-06-11
Regulatory Status
RX
Drug Name
FENTANYL-25
Product Number
1
Dosage Form
-
Strength
25MCG/HR
Approval Date
2011-02-09
Active Ingredient
FENTANYL
Application Number
77154
Product Number
1
Dosage Form
-
Strength
25MCG/HR
Approval Date
2011-02-09
Regulatory Status
RX
Drug Name
FENTANYL-37
Product Number
6
Dosage Form
-
Strength
37.5MCG/HR
Approval Date
2020-01-14
Active Ingredient
FENTANYL
Application Number
77154
Product Number
6
Dosage Form
-
Strength
37.5MCG/HR
Approval Date
2020-01-14
Regulatory Status
RX
Drug Name
FENTANYL-50
Product Number
2
Dosage Form
-
Strength
50MCG/HR
Approval Date
2011-02-09
Active Ingredient
FENTANYL
Application Number
77154
Product Number
2
Dosage Form
-
Strength
50MCG/HR
Approval Date
2011-02-09
Regulatory Status
RX
Drug Name
FENTANYL-62
Product Number
7
Dosage Form
-
Strength
62.5MCG/HR
Approval Date
2020-01-14
Active Ingredient
FENTANYL
Application Number
77154
Product Number
7
Dosage Form
-
Strength
62.5MCG/HR
Approval Date
2020-01-14
Regulatory Status
RX
Drug Name
FENTANYL-75
Product Number
3
Dosage Form
-
Strength
75MCG/HR
Approval Date
2011-02-09
Active Ingredient
FENTANYL
Application Number
77154
Product Number
3
Dosage Form
-
Strength
75MCG/HR
Approval Date
2011-02-09
Regulatory Status
RX
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
325MG;10MG
Approval Date
2000-07-26
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
40400
Product Number
1
Dosage Form
-
Strength
325MG;10MG
Approval Date
2000-07-26
Regulatory Status
RX
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
300MG;5MG
Approval Date
2017-03-31
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
206718
Product Number
1
Dosage Form
-
Strength
300MG;5MG
Approval Date
2017-03-31
Regulatory Status
RX
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
2
Dosage Form
-
Strength
300MG;7.5MG
Approval Date
2017-03-31
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
206718
Product Number
2
Dosage Form
-
Strength
300MG;7.5MG
Approval Date
2017-03-31
Regulatory Status
RX
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
3
Dosage Form
-
Strength
300MG;10MG
Approval Date
2017-03-31
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
206718
Product Number
3
Dosage Form
-
Strength
300MG;10MG
Approval Date
2017-03-31
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
8MG
Approval Date
2004-12-23
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
76855
Product Number
1
Dosage Form
-
Strength
8MG
Approval Date
2004-12-23
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2007-09-19
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
76855
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2007-09-19
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2007-09-19
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
76855
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2007-09-19
Regulatory Status
RX
Drug Name
LEVORPHANOL TARTRATE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2019-12-13
Active Ingredient
LEVORPHANOL TARTRATE
Application Number
212024
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2019-12-13
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
7
Dosage Form
-
Strength
70MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
211840
Product Number
7
Dosage Form
-
Strength
70MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-12-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
218850
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2024-12-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
218850
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2024-12-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
218850
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2024-12-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
218850
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2024-12-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
218850
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2024-12-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
218850
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2004-04-27
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
40517
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2004-04-27
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2004-04-27
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
40517
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2004-04-27
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2005-07-12
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
77142
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2005-07-12
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2019-08-22
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
207368
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2019-08-22
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2019-10-02
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
207537
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2019-10-02
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG/5ML
Approval Date
2019-10-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
207537
Product Number
2
Dosage Form
-
Strength
10MG/5ML
Approval Date
2019-10-01
Regulatory Status
RX
Drug Name
METHADOSE
Product Number
2
Dosage Form
-
Strength
10MG/ML
Approval Date
1982-01-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
17116
Product Number
2
Dosage Form
-
Strength
10MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
METHADOSE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
1993-04-29
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
74184
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
1993-04-29
Regulatory Status
RX
Drug Name
METHYLIN
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2002-12-19
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
21419
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2002-12-19
Regulatory Status
RX
Drug Name
METHYLIN
Product Number
2
Dosage Form
-
Strength
10MG/5ML
Approval Date
2002-12-19
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
21419
Product Number
2
Dosage Form
-
Strength
10MG/5ML
Approval Date
2002-12-19
Regulatory Status
RX
Drug Name
METHYLIN ER
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2000-05-09
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
75629
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2000-05-09
Regulatory Status
RX
Drug Name
METHYLIN ER
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2000-05-09
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
75629
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2000-05-09
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1998-11-27
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
40300
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1998-11-27
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1998-11-27
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
40300
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1998-11-27
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
1998-11-27
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
40300
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
1998-11-27
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2015-09-29
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
203583
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2015-09-29
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2015-09-29
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
203583
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2015-09-29
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2015-09-29
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
203583
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2015-09-29
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2015-09-29
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
203583
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2015-09-29
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2015-09-29
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
203583
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2015-09-29
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2015-09-29
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
203583
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2015-09-29
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2003-07-31
Active Ingredient
MORPHINE SULFATE
Application Number
76412
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2003-07-31
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2003-07-31
Active Ingredient
MORPHINE SULFATE
Application Number
76412
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2003-07-31
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
3
Dosage Form
-
Strength
60MG
Approval Date
2003-07-31
Active Ingredient
MORPHINE SULFATE
Application Number
76412
Product Number
3
Dosage Form
-
Strength
60MG
Approval Date
2003-07-31
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2003-07-03
Active Ingredient
MORPHINE SULFATE
Application Number
76438
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2003-07-03
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2003-07-03
Active Ingredient
MORPHINE SULFATE
Application Number
76438
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2003-07-03
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2011-07-15
Active Ingredient
MORPHINE SULFATE
Application Number
202348
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2011-07-15
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2023-08-21
Active Ingredient
MORPHINE SULFATE
Application Number
215194
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2023-08-21
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2023-08-21
Active Ingredient
MORPHINE SULFATE
Application Number
215194
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2023-08-21
Regulatory Status
RX
Drug Name
NALTREXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2002-03-22
Active Ingredient
NALTREXONE HYDROCHLORIDE
Application Number
76264
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2002-03-22
Regulatory Status
RX
Drug Name
NALTREXONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2002-03-22
Active Ingredient
NALTREXONE HYDROCHLORIDE
Application Number
76264
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2002-03-22
Regulatory Status
RX
Drug Name
NALTREXONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2002-03-22
Active Ingredient
NALTREXONE HYDROCHLORIDE
Application Number
76264
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2002-03-22
Regulatory Status
RX
Drug Name
OXYCET
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
1983-12-07
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
87463
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
1983-12-07
Regulatory Status
RX
Drug Name
OXYCODONE AND ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2004-06-30
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
40545
Product Number
1
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2004-06-30
Regulatory Status
RX
Drug Name
OXYCODONE AND ACETAMINOPHEN
Product Number
2
Dosage Form
-
Strength
325MG;10MG
Approval Date
2004-06-30
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
40545
Product Number
2
Dosage Form
-
Strength
325MG;10MG
Approval Date
2004-06-30
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2004-06-30
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
76758
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2004-06-30
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2004-06-30
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
76758
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2004-06-30
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2007-03-19
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
76758
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2007-03-19
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2021-10-12
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
76758
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2021-10-12
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2021-10-12
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
76758
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2021-10-12
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2018-04-30
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
210758
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2018-04-30
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG/5ML
Approval Date
2018-04-30
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
210758
Product Number
2
Dosage Form
-
Strength
100MG/5ML
Approval Date
2018-04-30
Regulatory Status
RX
Drug Name
POSACONAZOLE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2022-05-10
Active Ingredient
POSACONAZOLE
Application Number
212226
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2022-05-10
Regulatory Status
RX
Drug Name
PRUCALOPRIDE SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2025-06-24
Active Ingredient
PRUCALOPRIDE SUCCINATE
Application Number
219193
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2025-06-24
Regulatory Status
RX
Drug Name
PRUCALOPRIDE SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2025-06-24
Active Ingredient
PRUCALOPRIDE SUCCINATE
Application Number
219193
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2025-06-24
Regulatory Status
RX
Drug Name
RESTORIL
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
1982-01-01
Active Ingredient
TEMAZEPAM
Application Number
18163
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
RESTORIL
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
1982-01-01
Active Ingredient
TEMAZEPAM
Application Number
18163
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
RESTORIL
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
1991-10-25
Active Ingredient
TEMAZEPAM
Application Number
18163
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
1991-10-25
Regulatory Status
RX
Drug Name
RESTORIL
Product Number
4
Dosage Form
-
Strength
22.5MG
Approval Date
2004-11-02
Active Ingredient
TEMAZEPAM
Application Number
18163
Product Number
4
Dosage Form
-
Strength
22.5MG
Approval Date
2004-11-02
Regulatory Status
RX
Drug Name
ROXICODONE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2000-08-31
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
21011
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2000-08-31
Regulatory Status
RX
Drug Name
ROXICODONE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2000-08-31
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
21011
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2000-08-31
Regulatory Status
RX
Drug Name
ROXICODONE
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2009-05-15
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
21011
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2009-05-15
Regulatory Status
RX
Drug Name
TOFACITINIB CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2026-06-03
Active Ingredient
TOFACITINIB CITRATE
Application Number
219395
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2026-06-03
Regulatory Status
RX
Drug Name
TOFACITINIB CITRATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2026-06-03
Active Ingredient
TOFACITINIB CITRATE
Application Number
219395
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2026-06-03
Regulatory Status
RX
Drug Status Breakdown
119 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACETAMINOPHEN AND CODEINE PHOSPHATE
Application Number
40419
Product Number
1
Active Ingredient
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form
-
Strength
300MG;15MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.